Abstract B7: TSU-68 suppresses the progression of malignant pleural mesothelioma cells in SCID mice by inhibiting angiogenesis

Trung The Van(Tokushima University), Saburo Sone(Io Therapeutics (United States)), Hisatsugu Goto(Tokushima University), Yasuhiko Nishioka(Tokushima University), Soji Kakiuchi(Tokushima Prefectural Central Hospital), Takuya Kuramoto(Tokushima University), Tetsuo Taniguchi(Komaki City Hospital), Yoshitaka Sekido(Aichi Cancer Center)
Molecular Cancer Therapeutics
December 1, 2009
10.1158/1535-7163.targ-09-b7
Cited by 0

Related Papers

Hepatocyte Growth Factor Induces Gefitinib Resistance of Lung Adenocarcinoma with Epidermal Growth Factor Receptor–Activating Mutations
|Cancer Research|2008|642
Integrative Molecular Characterization of Malignant Pleural Mesothelioma
|Cancer Discovery|2018|630
Expression profiles of non-small cell lung cancers on cDNA microarrays: Identification of genes for prediction of lymph-node metastasis and sensitivity to anti-cancer drugs
|Oncogene|2003|324
Prediction of sensitivity of advanced non-small cell lung cancers to gefitinib (Iressa, ZD1839)
|Human Molecular Genetics|2004|175
The Neuromedin U-Growth Hormone Secretagogue Receptor 1b/Neurotensin Receptor 1 Oncogenic Signaling Pathway as a Therapeutic Target for Lung Cancer
|Cancer Research|2006|134